World's most trusted source for chemistry information, CAS, launches major biology expansion
COLUMBUS, Ohio, Feb. 1, 2022 /PRNewswire/ -- CAS, a division of the American Chemical Society specializing in scientific information solutions, announces the launch of a major expansion of the CAS SciFinder Discovery Platform into life sciences. The enhanced platform includes over 2 million modified biosequences, 60 years of patent literature, and one of the largest collections of journal information including PubMed's biomedical and life science data.
- Research in oncology and inflammatory diseases is showing great promise, and more recently we have seen the first approved mRNA vaccines for COVID-19.
- "This significant expansion of the CAS SciFinder Discovery Platform underscores our commitment to life sciences by providing molecular biology researchers the high-quality information that chemists have relied on CAS for over the last 110 years."
- The CAS SciFinder Discovery Platform expansion unlocks human-indexed insights from journals and patents in over 50 languages dating back to 1957 and 70 million biosequences curated by CAS scientists.
- About CAS: CAS is a leader in scientific information solutions, partnering with innovators around the world to accelerate scientific breakthroughs.